• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过 NMR 和晶体学研究阿瑞匹坦拮抗剂与人类 P 物质受体的结合模式。

Human substance P receptor binding mode of the antagonist drug aprepitant by NMR and crystallography.

机构信息

State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Pudong, Shanghai, 201203, China.

CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.

出版信息

Nat Commun. 2019 Feb 7;10(1):638. doi: 10.1038/s41467-019-08568-5.

DOI:10.1038/s41467-019-08568-5
PMID:30733446
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6367319/
Abstract

Neurokinin 1 receptor (NK1R) has key regulating functions in the central and peripheral nervous systems, and NK1R antagonists such as aprepitant have been approved for treating chemotherapy-induced nausea and vomiting. However, the lack of data on NK1R structure and biochemistry has limited further drug development targeting this receptor. Here, we combine NMR spectroscopy and X-ray crystallography to provide dynamic and static characterisation of the binding mode of aprepitant in complexes with human NK1R variants. F-NMR showed a slow off-rate in the binding site, where aprepitant occupies multiple substates that exchange with frequencies in the millisecond range. The environment of the bound ligand is affected by the amino acid in position 2.50, which plays a key role in ligand binding and receptor signaling in class A GPCRs. Crystal structures now reveal how receptor signaling relates to the conformation of the conserved NPxxY motif in transmembrane helix VII.

摘要

神经激肽 1 受体(NK1R)在中枢和外周神经系统中具有关键的调节功能,NK1R 拮抗剂,如阿瑞匹坦,已被批准用于治疗化疗引起的恶心和呕吐。然而,由于缺乏 NK1R 结构和生物化学方面的数据,限制了针对该受体的进一步药物开发。在这里,我们结合 NMR 光谱和 X 射线晶体学,提供了阿瑞匹坦与人 NK1R 变体复合物结合模式的动态和静态特征。F-NMR 显示在结合部位的离解速率较慢,其中阿瑞匹坦占据多个亚状态,以毫秒级的频率进行交换。结合配体的环境受位置 2.50 处氨基酸的影响,该氨基酸在配体结合和 A 类 GPCR 中的受体信号转导中起关键作用。晶体结构现在揭示了受体信号转导如何与跨膜螺旋 VII 中的保守 NPxxY 基序的构象相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5cb/6367319/159f00e7c847/41467_2019_8568_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5cb/6367319/28a6bf13988e/41467_2019_8568_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5cb/6367319/be2b4f3d0371/41467_2019_8568_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5cb/6367319/159f00e7c847/41467_2019_8568_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5cb/6367319/28a6bf13988e/41467_2019_8568_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5cb/6367319/be2b4f3d0371/41467_2019_8568_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5cb/6367319/159f00e7c847/41467_2019_8568_Fig4_HTML.jpg

相似文献

1
Human substance P receptor binding mode of the antagonist drug aprepitant by NMR and crystallography.通过 NMR 和晶体学研究阿瑞匹坦拮抗剂与人类 P 物质受体的结合模式。
Nat Commun. 2019 Feb 7;10(1):638. doi: 10.1038/s41467-019-08568-5.
2
GPCR large-amplitude dynamics by F-NMR of aprepitant bound to the neurokinin 1 receptor.阿瑞匹坦结合神经激肽 1 受体的 F-NMR 研究 G 蛋白偶联受体的大振幅动力学。
Proc Natl Acad Sci U S A. 2022 Apr 12;119(15):e2122682119. doi: 10.1073/pnas.2122682119. Epub 2022 Apr 4.
3
Crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists.人神经激肽 1 受体与临床使用的拮抗剂复合物的晶体结构。
Nat Commun. 2019 Jan 3;10(1):17. doi: 10.1038/s41467-018-07939-8.
4
Crystal structure of the human NK tachykinin receptor.人 NK 神经激肽受体的晶体结构。
Proc Natl Acad Sci U S A. 2018 Dec 26;115(52):13264-13269. doi: 10.1073/pnas.1812717115. Epub 2018 Dec 11.
5
Anti-HIV-1 activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretrovirals.神经激肽-1 受体拮抗剂阿瑞匹坦抗 HIV-1 的活性及其与其他抗逆转录病毒药物的协同作用。
AIDS. 2010 Nov 27;24(18):2789-96. doi: 10.1097/QAD.0b013e3283405c33.
6
Radiochemical Synthesis and Evaluation of Novel Radioconjugates of Neurokinin 1 Receptor Antagonist Aprepitant Dedicated for NK1R-Positive Tumors.新型神经激肽 1 受体拮抗剂阿瑞匹坦放射性缀合物的放射性化学合成与评价,用于 NK1R 阳性肿瘤。
Molecules. 2020 Aug 18;25(16):3756. doi: 10.3390/molecules25163756.
7
Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.肝癌细胞表达截断的神经激肽-1 受体,阿瑞匹坦可在体外和体内抑制其生长。
J Hepatol. 2014 May;60(5):985-94. doi: 10.1016/j.jhep.2013.12.024. Epub 2014 Jan 8.
8
Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIV.NK1R拮抗剂阿瑞匹坦作为HIV辅助治疗的药理学原理。
J Transl Med. 2016 May 26;14(1):148. doi: 10.1186/s12967-016-0904-y.
9
Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant.阿瑞匹坦对人脑中神经激肽1受体占有率的正电子发射断层扫描研究。
Biol Psychiatry. 2004 May 15;55(10):1007-12. doi: 10.1016/j.biopsych.2004.02.007.
10
Substance P and the Neurokinin-1 Receptor: The New CRF.P 物质和神经激肽-1 受体:新的 CRF。
Int Rev Neurobiol. 2017;136:151-175. doi: 10.1016/bs.irn.2017.06.008. Epub 2017 Aug 18.

引用本文的文献

1
Challenging activity and signaling bias in tachykinin NK1 and NK2 receptors by truncated neuropeptides.截短神经肽对速激肽NK1和NK2受体的挑战性活性及信号偏向性
J Biol Chem. 2025 Jun;301(6):108522. doi: 10.1016/j.jbc.2025.108522. Epub 2025 Apr 19.
2
Molecular determinants of neuropeptide-mediated activation mechanisms in tachykinin NK1 and NK2 receptors.速激肽NK1和NK2受体中神经肽介导的激活机制的分子决定因素。
J Biol Chem. 2024 Dec;300(12):107948. doi: 10.1016/j.jbc.2024.107948. Epub 2024 Oct 30.
3
G Protein-Coupled Receptor-Ligand Pose and Functional Class Prediction.

本文引用的文献

1
Crystal structure of the human NK tachykinin receptor.人 NK 神经激肽受体的晶体结构。
Proc Natl Acad Sci U S A. 2018 Dec 26;115(52):13264-13269. doi: 10.1073/pnas.1812717115. Epub 2018 Dec 11.
2
NK1 receptor antagonists for depression: Why a validated concept was abandoned.用于治疗抑郁症的NK1受体拮抗剂:为何一个经过验证的概念被摒弃。
J Affect Disord. 2017 Dec 1;223:121-125. doi: 10.1016/j.jad.2017.07.042. Epub 2017 Jul 20.
3
Ring current shifts in (19)F-NMR of membrane proteins.膜蛋白的(19)F - 核磁共振中的环电流位移
G 蛋白偶联受体-配体构象和功能分类预测。
Int J Mol Sci. 2024 Jun 22;25(13):6876. doi: 10.3390/ijms25136876.
4
Evaluation of Phytochemicals against Therapeutic Targets of Allergic Rhinitis Using Computational Studies.利用计算研究评估植物化学物质对过敏性鼻炎治疗靶点的作用
Molecules. 2024 Apr 12;29(8):1765. doi: 10.3390/molecules29081765.
5
Structures of human gastrin-releasing peptide receptors bound to antagonist and agonist for cancer and itch therapy.与人胃泌素释放肽受体结合的拮抗剂和激动剂的结构用于癌症和瘙痒症的治疗。
Proc Natl Acad Sci U S A. 2023 Feb 7;120(6):e2216230120. doi: 10.1073/pnas.2216230120. Epub 2023 Feb 1.
6
Multiple tachykinins and their receptors characterized in the gastropod mollusk Pacific abalone: Expression, signaling cascades, and potential role in regulating lipid metabolism.多种速激肽及其受体在腹足纲软体动物——太平洋鲍中的特征:表达、信号级联反应,以及在调节脂质代谢中的潜在作用。
Front Endocrinol (Lausanne). 2022 Sep 12;13:994863. doi: 10.3389/fendo.2022.994863. eCollection 2022.
7
Molecular mechanism of allosteric modulation for the cannabinoid receptor CB1.大麻素受体 CB1 的变构调节的分子机制。
Nat Chem Biol. 2022 Aug;18(8):831-840. doi: 10.1038/s41589-022-01038-y. Epub 2022 May 30.
8
G Protein-coupled Receptor (GPCR) Reconstitution and Labeling for Solution Nuclear Magnetic Resonance (NMR) Studies of the Structural Basis of Transmembrane Signaling.G 蛋白偶联受体(GPCR)的重构和标记用于溶液核磁共振(NMR)研究跨膜信号转导的结构基础。
Molecules. 2022 Apr 20;27(9):2658. doi: 10.3390/molecules27092658.
9
Frontiers in Lichen Planopilaris and Frontal Fibrosing Alopecia Research: Pathobiology Progress and Translational Horizons.扁平苔藓性毛发脱失和额部纤维性秃发研究前沿:病理生物学进展与转化前景
JID Innov. 2022 Mar 1;2(3):100113. doi: 10.1016/j.xjidi.2022.100113. eCollection 2022 May.
10
The Many Faces of G Protein-Coupled Receptor 143, an Atypical Intracellular Receptor.非典型细胞内受体G蛋白偶联受体143的多种面貌
Front Mol Biosci. 2022 Apr 12;9:873777. doi: 10.3389/fmolb.2022.873777. eCollection 2022.
J Biomol NMR. 2016 May;65(1):1-5. doi: 10.1007/s10858-016-0022-4. Epub 2016 May 30.
4
Biased Gs versus Gq proteins and β-arrestin signaling in the NK1 receptor determined by interactions in the water hydrogen bond network.通过水氢键网络中的相互作用确定NK1受体中偏向性的Gs与Gq蛋白及β-抑制蛋白信号传导。
J Biol Chem. 2015 Oct 2;290(40):24495-508. doi: 10.1074/jbc.M115.641944. Epub 2015 Aug 12.
5
Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexant.人源 OX2 食欲素受体与失眠药物苏沃雷生复合物的晶体结构
Nature. 2015 Mar 12;519(7542):247-50. doi: 10.1038/nature14035. Epub 2014 Dec 22.
6
Modified T4 Lysozyme Fusion Proteins Facilitate G Protein-Coupled Receptor Crystallogenesis.修饰的T4溶菌酶融合蛋白促进G蛋白偶联受体晶体生成。
Structure. 2014 Nov 4;22(11):1657-64. doi: 10.1016/j.str.2014.08.022. Epub 2014 Oct 23.
7
Allosteric sodium in class A GPCR signaling.A类G蛋白偶联受体信号传导中的变构钠
Trends Biochem Sci. 2014 May;39(5):233-44. doi: 10.1016/j.tibs.2014.03.002. Epub 2014 Apr 21.
8
Structure of the agonist-bound neurotensin receptor.激动剂结合神经降压素受体的结构。
Nature. 2012 Oct 25;490(7421):508-13. doi: 10.1038/nature11558. Epub 2012 Oct 10.
9
Identification of a crucial amino acid in the helix position 6.51 of human tachykinin neurokinin 1 and 3 receptors contributing to the insurmountable mode of antagonism by dual NK₁/NK₃ antagonists.鉴定出人神经激肽 1 和 3 受体螺旋位置 6.51 中的关键氨基酸,该氨基酸有助于双重 NK₁/NK₃ 拮抗剂产生不可逾越的拮抗模式。
J Med Chem. 2012 Jun 14;55(11):5061-76. doi: 10.1021/jm2017072. Epub 2012 May 22.
10
Exploiting structure similarity in refinement: automated NCS and target-structure restraints in BUSTER.在精修中利用结构相似性:BUSTER中的自动非晶体学对称性及目标结构约束
Acta Crystallogr D Biol Crystallogr. 2012 Apr;68(Pt 4):368-80. doi: 10.1107/S0907444911056058. Epub 2012 Mar 16.